Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics

Published:2019-01 Issue:1 Volume:27 Page:188-199
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Khoshnejad Makan,Patel Ami,Wojtak Krzysztof,Kudchodkar Sagar B.,Humeau Laurent,Lyssenko Nicholas N.,Rader Daniel J.,Muthumani Kar,Weiner David B.

Funder

Inovio Pharmaceuticals

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference82 articles.

1. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association;Benjamin;Circulation,2017

2. Hyperlipidemia as a risk factor for cardiovascular disease;Nelson;Prim. Care,2013

3. Atherosclerotic cardiovascular disease risk and evidence-based management of cholesterol;Roy;N. Am. J. Med. Sci.,2014

4. A century of cholesterol and coronaries: from plaques to genes to statins;Goldstein;Cell,2015

5. Preventing early cardiovascular death in patients with familial hypercholesterolemia;Repas;J. Am. Osteopath. Assoc.,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in novel delivery technologies to improve efficacy of therapeutic antibodies;Antiviral Research;2024-05

2. Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection;Microbial Cell Factories;2024-03-25

3. Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies;Annals of Medicine & Surgery;2024-03-12

4. In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates;Emerging Microbes & Infections;2024-02-28

5. Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management;Journal of Clinical Medicine;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3